Telix Pharmaceuticals launches information site on illumet™ prostate cancer imaging product
Melbourne (Australia) – 29 Jan 2019. – Telix has launched an information site on our illumet™ prostate cancer imaging product.
Telix has just launched an information site on our illumet™ prostate cancer imaging product. The website provides an informative depository about how the product works and its potential in clinical use for prostate cancer. Illumet™ contains everything a nuclear medicine pharmacist needs in order to prepare a dose of “patient-ready” 68Ga PSMA-11. The kit comes in different configurations to support all three major 68Ga generators available in the United States: EZAG, IRE, and ITG.
To visit our illumet™ site click here